AlphaNooner by AdvisorShares

Jesse Redmond, Chief Strategy & Investor Relations Officer at LEEF, joins Mackenzie Peterson to discuss California expansion, building for future interstate commerce, international opportunities, and the company's growth strategy. Chapters 0:00 Introduction and background 2:12 Leaf Brands overview 7:10 Farm development and standards 10:22 Himalaya acquisition and team 13:43 Operational goals a...

Dan Ahrens, Chief Operating Officer at AdvisorShares, joins Mackenzie Peterson to discuss the themes driving investor attention in 2026, the stocks leading those trends, and where he sees opportunity heading into the final months of the year. Chapters 0:00 Market overview 5:09 Cannabis sector analysis 13:29 Exchange listings and reform 19:11 Industry growth and future 24:12 AI, data, and industria...

John Lewis, Senior Portfolio Manager at Nasdaq Dorsey Wright, joins AlphaNooner to discuss what relative strength is telling us about the market today, where he's seeing strength, and the areas investors should be watching. AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the s...

Dan Ahrens and Noah Hamman join AlphaNooner from New York to break down the market moves, headlines, and investment themes that mattered most this week, ahead of Glass House Brands ringing the NYSE Closing Bell. AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the stories shapi...

Vireo Growth's Sammy Armenia joins AlphaNooner to discuss how rescheduling is changing the cannabis playbook, from capital allocation and M&A to growth strategy, competitive positioning, and what comes next for the industry. Chapters 0:00 Introduction and industry view 1:04 Vireo's growth and strategy 6:16 Operational performance metrics 13:33 Federal landscape and reform 19:44 Industry challe...

Sam Gibbons, SVP of Corporate Affairs at Village Farms, joins AlphaNooner to break down where the cannabis market may be headed and where Village Farms sees its biggest opportunities. From record cannabis growth and international expansion to the evolving U.S. landscape, Sam shares what investors should be watching next. Chapters 0:00 Introduction to Village Farms 1:11 Company background 4:22 Sam'...

AdvisorShares' Dan Ahrens joins AlphaNooner to discuss the trends driving opportunity in 2026, with a focus on biotech and psychedelic biotech, as well as the latest developments across cannabis. We look at recent performance across these themes, what's behind the moves, and what investors should be watching next. AlphaNooner by AdvisorShares brings you timely conversations with investors, market...

Dr. Ron Piccinini joins AlphaNooner to discuss how investors can balance growing market risks with the risk of getting too defensive too soon. We'll look at what his models are signaling, where vulnerabilities may be building, and how to manage exposure while staying positioned if the rally has further to run. AlphaNooner by AdvisorShares brings you timely conversations with investors, market stra...

Ascend Wellness CEO Sam Brill joins AlphaNooner to discuss the road ahead for Ascend and the U.S. cannabis industry, including the operating environment, evolving regulatory landscape, and the developments that could matter most for cannabis companies and investors from here. Chapters 0:00 Industry update and outlook 2:19 Rescheduling developments 7:22 Regulatory timeline and risks 10:05 Legal mar...

Joe Moore, CEO & Co-Founder of Psychedelics Today, joins the AlphaNooner to unpack the science, culture, and evolving landscape of psychedelics and psychedelic-assisted therapy. AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the stories shaping what comes next. Watch the...

Dan Ahrens joins AlphaNooner to share his perspective on the investment themes shaping markets today, the trends he's watching most closely, and where he sees opportunity-including the latest developments across the cannabis space. AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes a...

Dane Stevens, CEO & Co-Founder of Optimi Health, joins the AlphaNooner to discuss the company's work at the intersection of psychedelic medicine and mental health, the evolving psychedelic landscape, and Optimi's vision for the future. Stevens shares insights on the company's strategy, opportunities in the emerging market, and what investors should be watching next. AlphaNooner by AdvisorShare...

Rubicon Organics CEO Margaret Brodie joins the AlphaNooner in this pre-recorded conversation, filmed August 13, to unpack earnings, highlight key shifts in the premium cannabis market, and lay out what's next for Rubicon Organics. Quick, clear insight on strategy, momentum, and where the story goes from here. AlphaNooner by AdvisorShares brings you timely conversations with investors, market strat...

Ian Saunders, Head of Research at Nasdaq Dorsey Wright, looks at today's market through the lens of relative strength, breaking down where leadership is emerging, how market participation is shifting, and what the data may be signaling for investors from here. AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on...

Todd Harrison, Founding Partner and CIO of CB1 Capital, joins AlphaNooner following the NYSE closing bell to discuss why he believes cannabis is entering a pivotal new chapter. With rescheduling moving forward, listing and custody catalysts on the horizon, and capital still largely sidelined, Todd breaks down the disconnect between improving fundamentals and investor sentiment, where he sees oppor...

Back in the studio after a big day at the NYSE, host Mackenzie Peterson runs through the charts to watch today. We look at how markets are moving during a typically quiet August, key stories from earnings season, and the latest in cannabis as the industry approaches the August 17 deadline for briefs in the federal rescheduling process. AlphaNooner by AdvisorShares brings you timely conversations w...

AlphaNooner comes to you live from New York after a historic bell ringing at the New York Stock Exchange. We reflect on what the moment means for cannabis investing and the operators, long-time investors and advocates who helped get the industry to this point, share a behind-the-scenes look at the day, and check in on how cannabis stocks are trading. AlphaNooner by AdvisorShares brings you timely...

Todd Shapiro returns to AlphaNooner to share his perspective on where psychedelics go from here. We discuss how the psychedelic industry has evolved over the past few years, why the pace and momentum have picked up recently, the stages a newer industry has to move through, and the latest changes in his own role on the company side of the space. AlphaNooner by AdvisorShares brings you timely conver...

Jushi Chief Strategy Officer Trent Woloveck joins AlphaNooner to discuss the company's latest earnings, U.S. redomiciling, and the strategic priorities shaping its next phase of growth. From Virginia's evolving cannabis market to the industry's path toward broader investor access and a potential post-Schedule III landscape, Trent shares how Jushi is positioning for the opportunities ahead and the...

AdvisorShares' Dan Ahrens joins AlphaNooner in the studio to break down what's driving markets in the middle of earnings season. We discuss the strong earnings trends across his key themes, including HVAC and AI data center infrastructure, why some companies are selling off even after beating estimates and raising guidance, and the latest developments in cannabis. AlphaNooner by AdvisorShares brin...

AdvisorShares CEO Noah Hamman joins AlphaNooner to put the latest market moves in focus. We discuss the wave of consolidation across industries, what pharmaceutical mergers and drug pricing policy could mean for global drug makers, how regulators are approaching deal-making, and how AI is changing the way people create and consume content. AlphaNooner by AdvisorShares brings you timely conversatio...

AdvisorShares CEO Noah Hamman joins AlphaNooner for a Friday market check-in on what mattered this week. Against a backdrop of volatility, earnings season and a Fed meeting, we look at the week's biggest market moves and headline stories, notable earnings winners and losers, and what investors should keep in mind heading into next week. AlphaNooner by AdvisorShares brings you timely conversations...

In this solo edition of AlphaNooner, host Mackenzie Peterson walks through the key charts worth watching in the middle of earnings season. We look at the broad market's rebound, the ongoing divergence in tech, where relative strength is showing up around the world, and the latest developments across cannabis and psychedelics, plus a preview of an upcoming NYSE bell ringing. AlphaNooner by AdvisorS...

Loren DeFalco, Partner & Head of Research at CB1 Capital, joins AlphaNooner to discuss how the cannabis industry is evolving beyond regulation and into its next stage of medical adoption. The conversation explores the post-rescheduling landscape, the expanding body of clinical research, physician acceptance, and what these developments could mean for patients, operators, and investors as canna...

AdvisorShares' Dan Ahrens joins AlphaNooner to dig into the themes shaping markets, starting with HVAC and industrials, how those stocks have diverged from semiconductors and the broader market, and what's working and what isn't in the space. Plus, a check-in on cannabis as the industry awaits the next steps in the federal rescheduling process. AlphaNooner by AdvisorShares brings you timely conver...